NCT07825350: HTO and Tranexamic Acid Study
- State
- Not started
- Phase
- Phase 3
- People
- 200 planned
- Started
- 1 Jan 2027
- Primary completion
- 1 Jan 2030
- Arms
- SOC + Tranexamic Acid
- Results
- None posted
- 17 Sep 2026: Trial registered
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.
Kind of treatment: Drug.
Also known as Cyclo-f, Cyklokapron, Espercil, Femstrual, Haematrix, Lysteda, Rikavarin, TRANEXAMIC ACID 1 G in 10 mL INTRAVENOUS INJECTION, SOLUTION, Transamin, Tranexamic Acid 500 MG, Tranexamic acid tablets.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.